27.09.2011 • News

AmerisourceBergen To Buy Theracom For $250 Million

Pharmaceutical services company AmerisourceBergen announced the signing of a definitive agreement to purchase Theracom a subsidiary of CVS Caremark for $250 million. The acquisition is expected to be neutral to fiscal year 2012 earnings, and slightly accretive in fiscal 2013.

Theracom, with an annualized revenues of around $700 million, provides a wide range of support to pharmaceutical and biotechnology drug manufacturers including consulting and reimbursement services and deal will be closed in the first quarter, ending December 31. The combination is expected to expand AmerisourceBergen's reimbursement, adherence and patient access services for pharmaceutical and biotech.

Theracom will join Lash Group as part of AmerisourceBergen Consulting Services. Lash Group and Theracom will offer an extensive platform of services and solutions to support the growing demand for patient access and reimbursement services, and support the need for unique distribution solutions.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.